Found 10 matching trials
Pulpotomy Medications in Primary Teeth
NAthis study is aimed to evaluate and compare the pulp response to ACTIVA Bio...
Location
Suez Canal University
Osteopontin in Metastatic Breast Cancer Patients
N/AOPN plays an important role in various aspects of malignancy, particularly ...
Location
Mansoura University Oncology Center
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)
N/AStudy Objectives\*
1. Provide a systematic evaluation of the treatment out...
Location
Tri-Service General Hospital Hemophilia Care Center
Serum Biomarkers in Diagnosis of Mesothelioma
N/AIn this study, the investigators analyzed the efficiencies of hyaluronan, o...
Location
ESOGU Lung and Pleural Cancer Application and Research Center
Markers of Vascular Calcification in Diabetic Nephropathy in Patients With Diabetic Nephropathy
N/AThe study will be conducted at Assiut University Hospital. Eligible subject...
Location
Assiut University
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
N/AThis study aims to investigate the correlation of serum osteopontin level a...
Location
Multiple Locations
PET/CT for the Quantification of Atherosclerotic Plaque Inflammation
N/AThis is a single-centre prospective trial with 140 patients employing \[18F...
Location
Department of Nuclear Medicine, Departmen of Cardiology, University of Munich
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
NAOsteoporosis is one of the most common chronic skeletal disorders, particul...
Location
AL-KUFA UNIVERSITY/College of Pharmacy
Maternal Serum Osteopontin Levels in Pregnant Women Diagnosed With PPROM
N/APreterm prelabor rupture of membranes (PPROM) is defined as the rupture of ...
Location
Private Zilan Hospital
Natalizumab Treatment of Progressive Multiple Sclerosis
PHASE2The purpose of this study is to study safety and efficacy of natalizumab tr...
Location
Danish Multiple Sclerosis Center, Section 2082, Rigshospitalet